NHS: Brexit-related Risks

Lord Bassam of Brighton Excerpts
Thursday 5th July 2018

(5 years, 10 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Asked by
Lord Bassam of Brighton Portrait Lord Bassam of Brighton
- Hansard - -

To ask Her Majesty’s Government what assessment they have made of (1) the risks to the National Health Service, and (2) the implications for access to medical supplies, of the United Kingdom leaving the European Union without a withdrawal agreement.

None Portrait Noble Lords
- Hansard -

Hear, hear.

--- Later in debate ---
Lord O'Shaughnessy Portrait The Parliamentary Under-Secretary of State, Department of Health and Social Care (Lord O'Shaughnessy) (Con)
- Hansard - - - Excerpts

Nearly there.

My Lords, patient safety is our priority in the exit negotiations, and maintaining continuity of supply of medical products is a key part of ensuring that patients continue to receive safe, high-quality care from day one after we leave the European Union. Extensive work has been undertaken to understand the implications of our EU exit on the NHS, considering a range of negotiation outcomes, including exit without a withdrawal agreement. This has included a focus on continued access to medical supplies.

Lord Bassam of Brighton Portrait Lord Bassam of Brighton (Lab)
- Hansard - -

My Lords, I congratulate the noble Lord on his stamina this morning—more Fleetwood Mac than Iron Maiden. Given that the Government seem a long way off getting any sort of Brexit deal on goods and services, will the Minister tell the House whether there is a plan B to ensure that the NHS has continuity of medical supplies, and will he explain how he expects the interface of the medicines approval regime and the international regulation of medicines to work post Brexit? Will he also guarantee comparable levels of patient safety after we leave the EU?

Lord O'Shaughnessy Portrait Lord O'Shaughnessy
- Hansard - - - Excerpts

I am glad that the noble Lord’s train got him here in time for him to ask his Question. First, I do not share his pessimism about the outcome. We will publish the White Paper on our proposals next week and we expect it to get a warm welcome—and not just in this House. Nevertheless, it would be wrong if we were not working on contingency options. I think that the public would be surprised if we were not planning for every scenario. That is precisely what we are doing at the moment, and of course, as we do that, patient safety is our number one priority. We need to make sure that the supply of medicines and medical devices can come in to the country and be used by NHS patients, come what may.